Prospective Multicenter Randomized Controlled Trial On Two-Stage Turnbull-Cutait Coloanal Anastomosis For Rectal
- Conditions
- Rectal Neoplasm
- Interventions
- Procedure: Hand-sewn coloanal anastomosisProcedure: Two staged Turnbull-Cutait procedureProcedure: Ultralow anterior rectal resection with total mesorectal excision
- Registration Number
- NCT01766661
- Lead Sponsor
- Hospital Universitari de Bellvitge
- Brief Summary
The aim of this study is to decrease the morbidity by 30% using the Turnbull-Cutait procedure in comparison to the standard surgery for low rectal cancer. The investigators compare quality of life, faecal incontinence and recurrence of neoplasm in patients who received standard colo-anal anastomosis with protective ileostomy or two-staged Turnbull-Cutait colo-anal anastomosis after Low Anterior Resection for rectal cancer.
- Detailed Description
Anastomotic leak represents the most frequent complication after rectal cancer surgery and a lateral covering ileostomy is usually performed to reduce its incidence. Other important consequences of rectal cancer surgery are alterations in bowel habits and function and a negative impact on quality of life. This prospective, randomized, multicenter and controlled trial compares post-operative complications, quality of life, faecal incontinence and recurrence rate in patients treated for low rectal cancer with colo-anal anastomosis protected by a lateral ileostomy or with a two-staged Turnbull-Cutait colo-anal anastomosis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 92
- Patients with adenocarcinoma of the lower-middle third of the rectum proctoscopy established by rigid proctoscopy, with histological confirmation and candidates of colo-anal anastomosis;
- Patients over 18 years and under 75 years, who can tolerate neoadjuvant and surgical treatment;
- Patients who undergo an ultra-low anterior rectal resection with total mesorectal excision and nerve and sphincter-sparing with curative intention
- Any extension of the primary tumor (T 1-2-3-4) according to the TNM classification;
- Patients with or without lymph node metastasis (N - / +) and with or without resectable distant metastases;
- Patients clinically without fecal incontinence prior to the current illness and with a Wexner incontinence Score less than or equal to 5;
- Patients ASA I, II or III and adequate hematological, renal and hepatic function;
- Patients who signed informed consent.
- Altered cognitive state(eg mental retardation or dementia) that prevents collaboration in the study or patients who can neither read nor write
- Fecal incontinence (Wexner equal to or greater than 6);
- Previous surgery or proctological, colonic and anorectal functional disease
- Diagnosis of synchronous colorectal or any other active neoplasm;
- Patients ASA IV, V;
- Pregnancy and lactation;
- Rejection of the patient to sign the consent form.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Two stage Turnbull-Cutait anastomosis Ultralow anterior rectal resection with total mesorectal excision Two staged coloanal anastomosis without protective ileostomy (Turnbull-Cutait procedure). Coloanal anastomosis with ileostomy Hand-sewn coloanal anastomosis Hand-sewn coloanal anastomosis protected by a loop ileostomy Coloanal anastomosis with ileostomy Ultralow anterior rectal resection with total mesorectal excision Hand-sewn coloanal anastomosis protected by a loop ileostomy Two stage Turnbull-Cutait anastomosis Two staged Turnbull-Cutait procedure Two staged coloanal anastomosis without protective ileostomy (Turnbull-Cutait procedure).
- Primary Outcome Measures
Name Time Method post-operative morbidity within the first 30 days after surgery
- Secondary Outcome Measures
Name Time Method local and/or distant recurrence of neoplasm 3 years Quality of life 3 years by COREFO questionnaire.
Fecal incontinence 3 years by Wexner Incontinence Score
Trial Locations
- Locations (4)
Istituto Nazionale Tumori "Fondazione G, Pascale" - IRCCS
🇮🇹Naples, Italy
Vall d'Hebron Universitary Hospital
🇪🇸Barcelona, Spain
Corporació Sanitària Parc Taulí Hospital Universitari
🇪🇸Sabadell, Barcelona, Spain
Bellvitge University Hospital
🇪🇸Barcelona, Spain